A Comprehensive Care Coordination and Management Platform for Alzheimer's Disease and Related Dementia (Care4AD)
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Phase 1/Phase 2
SUMMARY
Dementia, a chronic disease of aging, is characterized by progressive cognitive decline that interferes with independent functioning. The medical, psychological, social and functional sequelae of dementia cause great stress to patients, their caregivers, and their family. The investigator proposes to examine effectivness of a home-based care coordination and management device, called Care4AD to help caregivers effectively coordinate, manage, and improve dementia care.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: t
View:
• Older patients (\> 65 years old) with mild or moderate Alzheimer's Disease
• Must be ambulatory
• Must be in a residential home with a caregiver/informant.
Locations
United States
Texas
Baylor College of Medicine
RECRUITING
Houston
Baylor College of Medicine
ACTIVE_NOT_RECRUITING
Houston
Contact Information
Primary
Maria Noun, BS
maria.noun@bcm.edu
713-798-7538
Backup
Ilse Torres
ilse.torresruiz@bcm.edu
713-798-8714
Time Frame
Start Date: 2021-11-01
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 100
Treatments
Experimental: Intervention Group (IG): Care coordination with Care4AD system
All participants will receive Care4AD device.All reminders will be activated in the intervention group (IG). Essential activity daily living (ADL) tasks will be pre-programmed by our care coordination expert for the IG. Patients and their caregivers in the IG will be also able to schedule additional tasks.
No_intervention: Control Group (CG): Standard of care
Participants in control group (CG) will also receive Care4AD device. However, all reminders and programming of activity daily living (ADL) tasks will be de-activated in the CG.
Related Therapeutic Areas
Sponsors
Collaborators: BioSensics
Leads: Bijan Najafi, PhD